Accès ouvert
2020
article
OpenAlex
Tatyana G. Vishnyakova, Alexander V. Bocharov, Irina N. Baranova, Roger Kurlander et autres
SR-BI binds various lipoproteins, including HDL, LDL as well as VLDL, and mediates selective cholesteryl ester (CE) uptake. HDL derived CE accumulates in cellular lipid droplets (LDs), which also store triacylglycerol (TAG). We hypothesized that SR-BI could significantly facilitate LD formation, in …
us
(code pays fourni par la source)
Accès ouvert
2017
article
OpenAlex
Zhigang Chen, Thomas L. Eggerman, Alexander V. Bocharov, Irina N. Baranova et autres
Apolipoprotein B mRNA-editing enzyme catalytic subunit 3 (APOBEC-3) enzymes are cytidine deaminases that are broadly and constitutively expressed. They are often up-regulated during carcinogenesis and candidate genes for causing the major single-base substitution in cancer-associated DNA mutations. Moreover, APOBEC-3s are involved in …
us, au
(code pays fourni par la source)
2016
article
OpenAlex
Enkhtsetseg Purev, Georg Aue, Phuong Vo, Ritesh R. Kotecha et autres
Abstract Introduction: Allogeneic hematopoietic stem cell transplantation (HSCT) is curative for SAA unresponsive to immunosuppressive therapy (IST). For SAA patients (pts) with a HLA-identical sibling donor, the use of peripheral-blood (PB) grafts have been reported to have increased risk of graft-versus-host disease …
us
(code pays fourni par la source)
2016
article
OpenAlex
Mattias Carlsten, Robert Reger, Ritesh R. Kotecha, Enkhtsetseg Purev et autres
Abstract Background: For patients (pts) with severe aplastic anemia (SAA) lacking an HLA identical donor, outcomes of hematopoietic stem cell transplantation (HSCT) using unrelated cord blood (UCB) units or haplo-identical donors (HDs) have historically been associated with high graft failure rates and …
us
(code pays fourni par la source)
Accès ouvert
2016
article
OpenAlex
Jennifer N. Brudno, Robert Somerville, Victoria Shi, Jeremy J. Rose et autres
PURPOSE: Progressive malignancy is the leading cause of death after allogeneic hematopoietic stem-cell transplantation (alloHSCT). After alloHSCT, B-cell malignancies often are treated with unmanipulated donor lymphocyte infusions (DLIs) from the transplant donor. DLIs frequently are not effective at eradicating malignancy and often …
jp
(code pays fourni par la source)
Accès ouvert
2016
article
OpenAlex
Paneez Khoury, Ronan Desmond, Andrea Pabon, Nicole Holland‐Thomas et autres
BACKGROUND: With the exception of the presence of the FIP1L1-PDGFRA fusion gene, little is known about predictors of imatinib response in clinically-defined hypereosinophilic syndrome (HES). METHODS: Subjects with FIP1L1-PDGFRA-myeloid neoplasm (FP; n =12), PDGFRA-negative HES with ≥4 criteria suggestive of a myeloid …
us, ie
(code pays fourni par la source)
2015
article
OpenAlex
Enkhtsetseg Purev, Georg Aue, Ritesh R. Kotecha, Jennifer Wilder et autres
Abstract For SAA patients (pts) lacking an HLA identical donor, outcomes of HSCT using single or dual unrelated cord blood (UCB) transplants or haplo-identical donors have been associated with high graft failure rates and poor survival. We investigated whether co-infusion of a …
us
(code pays fourni par la source)
2015
article
OpenAlex
Jennifer N. Brudno, Robert Somerville, Victoria Shi, Jeremy J. Rose et autres
Introduction Progressive malignancy is the leading cause of death after allogeneic hematopoietic stem cell transplantation (alloHSCT). After alloHSCT, B-cell malignancies are often treated with infusions of unmanipulated donor lymphocytes (DLIs) from the transplant donor. DLIs are frequently not effective at eradicating malignancy, …
us
(code pays fourni par la source)
Accès ouvert
2015
article
OpenAlex
Weixin Wang, Meghan Corrigan-Cummins, Emily Barber, Layla M. Saleh et autres
us
(code pays fourni par la source)
Accès ouvert
2015
article
OpenAlex
Phuong Vo, Jeremy Pantin, Catalina Ramos, Lisa Cook et autres
Severe aplastic anemia (SAA) is a rare disorder leading to bone marrow failure, which if left untreated, is invariably fatal. Conventional therapies with immunosuppressive therapy or allogeneic hematopoietic stem cell transplantation (HSCT) are highly effective. HSCT can offer a greater outcome in …
us
(code pays fourni par la source)
Accès ouvert
2015
article
OpenAlex
Miriam E. Mossoba, David Halverson, Roger Kurlander, Bazetta Blacklock Schuver et autres
PURPOSE: We hypothesized that lymphoid-selective host conditioning and subsequent adoptive transfer of sirolimus-resistant allogeneic T cells (T-Rapa), when combined with high-dose sirolimus drug therapy in vivo, would safely achieve antitumor effects while avoiding GVHD. EXPERIMENTAL DESIGN: Patients (n = 10) with metastatic …
us, it
(code pays fourni par la source)
Accès ouvert
2015
article
OpenAlex
David Halverson, Miriam E. Mossoba, Brenna Hansen, Bazetta Blacklock Schuver et autres
We recently found that early pre-emptiveDLI with donor CD4+ T-Cells cultured in rapamycin (T-Rapa) allowed allo-engraftment after low-intensity fludarabine plus cyclophosphamide (Cy) host conditioning (Blood, 2013). To evaluate further reductions in conditioning intensity, we conducted a pilot clinical trial of allogeneic HSCT …
us
(code pays fourni par la source)